Advanced search
Publication Cover
Leukemia & Lymphoma Volume 52, 2011 - Issue 5
Submit an article Journal homepage
244
Views
9
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Anemia and erythropoiesis-stimulating agent administration in patients with non-Hodgkin lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisolone ± rituximab chemotherapy: results from an observational study

Corinne HaiounHematology Department, Henri Mondor Hospital, Creteil, FranceCorrespondence[email protected]
,
Antonio SalarHematology Department, Hospital del Mar, Barcelona, Spain
,
Ruth PettengellSt. George's University of London, London, UK
,
Hans Erik JohnsenAalborg Hospital Science and Innovation Center AHSIC, Aarhus University Hospital, Aalborg, Denmark
,
Ulrich DuehrsenDepartment of Hematology, University Hospital Essen, Essen, Germany
,
Francesca Gaia RossiUO Ematologia 1-CTMO, Fondazione Policlinico MaRe IRCCS, Milano, Italy
,
Gregor VerhoefUniversity Hospital, Leuven, Belgium
,
Matthias SchwenkglenksInstitute of Pharmaceutical Medicine, University of Basel, Switzerland
,
Ulrich JaegerDepartment of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
,
Lisa HamiltonBiostatistics, Amgen Ltd, Cambridge, UK
,
Beatriz PujolClinical Development, Amgen (Europe) GmbH, Zug, Switzerland
&
Pieternella Johanna LugtenburgDepartment of Hematology, Erasmus MC, Rotterdam, The Netherlands
 show all
Pages 796-803 | Received 30 Sep 2010, Accepted 16 Jan 2011, Published online: 21 Feb 2011

References

  • Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74–108.
  • Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002;346: 235–242.
  • Pfreundschuh M, Schubert J, Ziepert M, et al. Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60). Lancet Oncol 2008;9:105–116.
  • Delarue R, Tilly H, Salles G, et al. R-CHOP14 compared to R-CHOP21 in elderly patients with diffuse large B-cell lymphoma: results of the interim analysis of the LNH03-6B GELA study. Blood 2009;114(Suppl. 1): Abstract 406.
  • Pfreundschuh M, Trumper L, Kloess M, et al. Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL. Blood 2004; 104:634–641.
  • Bokemeyer C, Aapro MS, Courdi A, et al. EORTC guidelines for the use of erythropoietic proteins in anemic patients with cancer: 2006 update. Eur J Cancer 2007;43:258–270.
  • Aapro MS, Link H. September 2007 update on EORTC guidelines and anemia management with erythropoiesis-stimulating agents. Oncologist 2008;13(Suppl. 3):33–36.
  • Salar A, Haioun C, Rossi FG, et al. Febrile neutropenia risk assessment and granulocyte-colony stimulating factor support in patients with diffuse large B cell lymphoma receiving R-CHOP regimens. Blood 2009;114(Suppl. 1): Abstract 107.
  • Bokemeyer C, Aapro MS, Courdi A, et al. EORTC guidelines for the use of erythropoietic proteins in anemic patients with cancer. Eur J Cancer 2004;40:2201–2216.
  • Mark TL, McKenzie RS, Fastenau J, Piech CT. Retrospective observational study of patients with chemotherapy-related anemia receiving erythropoietic agents. Curr Med Res Opin 2005;21:1347–1354.
  • Pujade-Lauraine E, Richard AJ, Sapede C, Hayward C. Erythropoietic agents in anemic patients with cancer: a retrospective observational survey of epoetin alpha, epoetin beta and darbepoetin alpha use in routine clinical practice. Oncol Rep 2005;14:1037–1044.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.